Peptide record

TPDB44495

Antiviral standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44495
Antiviral
Anti-infective peptides
AI4AVP DRAVP 2.0 Peptipedia
standard
No
A 15-aa standard-residue antiviral peptide sequence curated from AI4AVP, DRAVP 2.0, and Peptipedia, with an available 3D structural model.
Sequence
TVAWDWVPKRPSVCT
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C80H121N21O21S1
NEQGHILMFY
V
1745.03
8.97
2
1
6
+1
1.19
-0.147
64.67
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
11000
6.30
4
Residue Composition
number
1
A
1
R
0
N
1
D
1
C
0
E
0
Q
0
G
0
H
0
I
0
L
1
K
0
M
0
F
2
P
1
S
2
T
2
W
0
Y
3
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 1 C: 1 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 1 M: 0 F: 0 P: 2 S: 1 T: 2 W: 2 Y: 0 V: 3
Chemical Descriptors
15 reviewed residue count
C80H121N21O21S1 sequence-only estimate (linear, free termini)
1745.03 sequence-only estimate (linear, free termini)
8.97 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
1.19 sequence-only estimate (linear, free termini)
-0.147 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0